Infection:对城市地区媒传疾病和其它感染性疾病进行现场验证和快速诊断试验

2018-11-29 MedSci MedSci原创

<p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;text-justify:inter-ideograph;line-height:normal">卫生人员在诊断城市地区的媒传疾病和其它贫困疾病方面仍面临许多挑战。因此,有必要知道哪些快速诊断技术目前是可用的,哪些已经得到

卫生人员在诊断城市地区的媒传疾病和其它贫困疾病方面仍面临许多挑战。因此,有必要知道哪些快速诊断技术目前是可用的,哪些已经得到了适当的评估,并正在城市环境中用于改善对这些疾病的控制。

研究人员分析最后纳入了179份来自最初筛选的7806份文件。报告诊断性能、影响和实施结果的研究,疟疾(n = 100)和结核病(n = 47)占了大多数。评估主要性能的少数研究为内脏利什曼病(n = 9),丝虫病和钩端螺旋体病(n = 5),伤寒肠热病和血吸虫病(每个n = 3),登革热和麻风(每个n = 3),及恰加斯病,非洲人类锥虫病,霍乱(每个n = 1)。报告快速检测变量的灵敏度取决于多个因素。总体而言,除血吸虫病和霍乱外,特异性较高(>80%)。,血吸虫病的。快速诊断试剂的影响和实施结果,主要是可接受性和成本,然后是适用性、可行性和可持续性正在现场环境中评估。实施快速检测的挑战包括从文化到技术以及行政问题。

研究发现,在城市环境中,快速诊断试验正被应用于对媒传疾病和其它贫困疾病的诊断,并已证明对病例检测有影响。然而,大多数证据来自疟疾快速诊断,且结果各不相同。虽然结核病和内脏利什曼病的快速检测需要进一步的实施研究,但对于登革热、恰加斯病、丝虫病、钩端螺旋体病、肠热病、人类非洲锥虫病、血吸虫病和霍乱,需要更多的证据证明目前检测的有效性或进一步开发新的替代方法。

原始出处:

Lyda Osorio, Jonny Alejandro, A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1665842, encodeId=b41a16658420b, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Dec 03 13:39:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026317, encodeId=aac1202631ef1, content=<a href='/topic/show?id=fa9a9165287' target=_blank style='color:#2F92EE;'>#诊断试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91652, encryptionId=fa9a9165287, topicName=诊断试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e183245, createdName=Eleven11, createdTime=Sat Mar 23 15:39:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655441, encodeId=93e4165544172, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sat Oct 26 14:39:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043541, encodeId=c6f020435412c, content=<a href='/topic/show?id=bdd445116e3' target=_blank style='color:#2F92EE;'>#媒传疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45116, encryptionId=bdd445116e3, topicName=媒传疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5eee468, createdName=zxl729, createdTime=Fri Mar 08 21:39:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524443, encodeId=882815244433a, content=<a href='/topic/show?id=f0f998396d' target=_blank style='color:#2F92EE;'>#Infection#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9839, encryptionId=f0f998396d, topicName=Infection)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76e211601877, createdName=lidong44, createdTime=Sat Dec 01 12:39:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353998, encodeId=c6f435399805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 29 22:37:49 CST 2018, time=2018-11-29, status=1, ipAttribution=)]
    2018-11-29 医者仁心5538

    学习了

    0

相关资讯

Lancet Infect Dis:2017美国感染性疾病周大会亮点

2017年第27届欧洲临床微生物和感染性疾病会议(European Congress of Clinical Microbiology and Infectious Diseases,ECCMID)10月4日至8日在圣地亚哥举行。San Diego对这次会议的亮点做了报道并发表在Lancet Infectious Diseases杂志。

PNAS:降胆固醇药——你意想不到的作用!降胆固醇药可能抗击感染性疾病

这种数字彩色扫描电子显微镜(SEM)图像显示侵入免疫细胞(黄色)的沙门氏菌(红色)。伤寒沙门氏菌是伤寒的原因。杜克研究人员发现,人类遗传变异可能会影响沙门氏菌入侵细胞和伤寒风险。

Intens Care Med:感染性疾病----我从来不相信的10个普遍真相

感染性疾病领域给我们带来了许多惊喜。即使在现代医学时代,疾病生物学和管理的发展的观点仍不时地挑战我们(图1)。各个科学领域知识的整合,开辟了一个令人兴奋的局面,动摇了我们在医学院或临床医学实践中习得的信念。表1列出了在某些医学进化因素的影响下形成的10个选定主题。

感染性疾病相关个体化医学分子检测技术指南

《指南》由国家卫计委个体化医学检测技术专家委员会编订,是国家卫计生委个体化医学检测技术系列指南之一,旨为临床实验室进行感染性疾病相关的个体化医学分子检测提供参考和指导。指南介绍了感染性疾病相关的个体化医学分子检测应注意的相关问题、技术方法、结果报告与解释、质量保证及临床应用等内容,主要适用于开展个体化医学分子检测的医疗机构临床检验实验室,同时供从事感染性疾病诊治的临床医师参考。

Emerg Infect Dis:1983-2015韩国感染性疾病死亡率趋势分析研究

感染性疾病/传染性疾病的发生率、死亡率往往与社会的经济、卫生水平相关。过去的20年,随着全球经济贸易一体化,韩国的经济也呈快速发展趋势,常见的感染性疾病/传染性疾病的发病率、死亡率总体降低,但是随着新发、突发传染病的出现(例如2009年的H1N1流感、2015年的中东呼吸综合征),老龄化的趋势,韩国感染性疾病/传染性疾病的防控工作迎来了新的挑战。

Eur Heart J:HDL与感染性疾病风险存在U型关系!

由此可见,一般人群中低浓度和高浓度HDL胆固醇的个体中分别21%和8%的患者发生感染性疾病的风险较高,但这些发现并不一定意味着存在因果关系。